It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for AlloVir Inc (ALVR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.04, or 2.44%, to $1.68. The AlloVir Inc has recorded 2,345 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that AlloVir to Present at the Piper Sandler 35th Annual Healthcare Conference.
AlloVir Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $1.64 and fluctuated between $1.7400 as its day high and $1.6039 as its day low. The current market capitalization of AlloVir Inc is $187.06M. A total of 0.83 million shares were traded on the day, compared to an average of 915.60K shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, ALVR has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 1,547 shares. Over the last 12 months, there were 12 BUYs and 23 SELLs from insiders. Insiders purchased 3,876,216 shares during that period but sold 200,511.
In the most recent transaction, Sinha Vikas sold 1,475 shares of ALVR for 1.54 per share on Oct 20. After the transaction, the insider now owns 1,170,239 company shares. In a previous transaction on Oct 20, Hagen Brett R sold 357 shares at 1.54 per share. ALVR shares that Chief Accounting Officer owns now total 126,238.
Among the insiders who sold shares, Brainard Diana disposed of 8,581 shares on Oct 19 at a per-share price of $1.58. This resulted in the Chief Executive Officer holding 881,977 shares of ALVR after the transaction. In another insider transaction, Sinha Vikas sold 1,232 shares at $1.58 per share on Oct 19. Company shares held by the insider now total 1,171,714.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for ALVR in the last 3 months, the mean price target is $19.50 with high estimates of $27.00 and low estimates of $14.00. In terms of 52-week highs and lows, ALVR has a high of $7.84 and a low of $1.31.
As of this writing, ALVR has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.34 per share and a lower estimate of -$0.44. The company reported an EPS of -$0.48 in the last quarter, which was -6.70% lower than expectations of -$0.45.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALVR’s latest balance sheet shows that the firm has $248.12M in Cash & Short Term Investments as of fiscal 2021. There were $30.07M in debt and $37.85M in liabilities at the time. Its Book Value Per Share was $1.71, while its Total Shareholder’s Equity was $225.27M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALVR is Buy with a score of 5.00.